Using objective and subjective criteria, we performed a study to assess the
long-term impact of functional endoscopic sinus surgery (FESS) in patients
with chronic rhinosinusitis and asthma at an average follow-up of 6.5 year
s. One hundred twenty patients who underwent FESS for chronic rhinosinusiti
s were followed up for an average of 6.5 years (range 6.0 to 10.6 years). S
eventy-two (60%) patients responded to a follow-up questionnaire, and 30 (4
2%) of them reported a history of asthma. Subjective levels of improvement
and assessments of medication need were evaluated and statistically assesse
d with parametric and nonparametric methods. Of these 30 patients, 27 (90%)
reported that their asthma was better than it had been before FESS, 6.5 ye
ars ago. Average reported improvement increased from 49% at 1.1 years after
surgery to 65% at 6.5 years after surgery. Asthma attacks declined in 20 o
f 27 (74.1%). Medication use for asthma showed similar improvement, with ap
proximately half reporting less inhaler usage and nearly two thirds reporti
ng less oral steroid use. This study demonstrates that a combination of FES
S, careful postoperative care, and appropriate medical therapy for chronic
rhinosinusitis has a favorable longterm effect on asthma in patients with s
ymptomatic chronic sinusitis. In this study asthma severity, frequency of a
ttacks, and medication need were all improved.